Abstract
A wide variety of skin diseases are caused by viruses. Cutaneous lesions may either reflect a direct skin infection by an epidermotropic virus, such as in molluscum contagiosum or Verrucae, or may be a reflection of a widespread viral infection, such as in measles or chicken pox. Finally, the human immunodeficiency virus (HIV) causes an almost endless list of skin findings primarily through the acquired immunodeficiency syndrome (AIDS).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Review
Memar O, Tyring SK (1995) Cutaneous viral infections. J Am Acad Dermatol 33:279 – 287
Warts
Archard HO, Heck JW, Stanley HR (1965) Focal epithelial hyperplasia: an unusual oral mucosal lesion found in Indian children. Oral Surg Oral Med oral Pathol 20:201
Baker GE, Tyring SK (1997) Therapeutic approaches to papillomavirus infections. Dermatol Clin 15:331–340
Benton EC (1997) Therapy of cutaneous warts. Clin Dermatol 15:449 – 455
Buschke A, Löwenstein L (1925) Über carcinomähnliche Condylomata acuminata des Penis. Klin Wochenschr 4:1726–1728
de Villiers EM (1994) Human pathogenic papillomavirus types: an update. In: zur Hausen H, ed. Human Pathogenic Papillomaviruses. Springer-Verlag Berlin Heidelberg
de Villiers EM (1997) Papillomavirus and HPV typing. Clin Dermatol 15(2): 199 – 206
Drake LA, Ceilley RI, Cornelison RL et al. (1995) Guidelines of care for warts: human papillomavirus. Committee on Guidelines of Care. J Am Acad Dermatol 32:98 – 103
Edwards L, Ferenczy A, Eron L et al. (1998) Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human Papilloma Virus. Arch Dermatol 134:25 – 30
Gross G, Rogozinski T, Schofer H et al. (1998) Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double-blind study in 120 patients. Dermatology 196:330–334
Jablonska S, Majewski S, Obalek S et al. (1997) Cutaneous warts. Clin Dermatol 15:309 – 319
Lee AN, Mallory SB (1999) Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts. J Am Acad Dermatol 41:595 – 599
Lewandowsky F, Lutz W (1922) Ein Fall einer bisher noch nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis) Arch Dermatol Syph 41:193 – 202
Majewski S, Jablonska S (1995) Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131:1312–1318
Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36:659 – 685
Routh HB, Bhowmik KR, Parish LC (1997) Myths, fables and even truths about warts and human papillomavirus. Clin Dermatol 15:305 – 307
Wikstrom A (1995) Clinical and serological manifestations of genital human papillomavirus infection. Acta Derm Venereol Stockh [Suppl] 193:1–85
Herpes Viruses
Alrabiah FA, Sacks SL (1996) New antiherpesvirus agents. Their targets and therapeutic potential. Drugs 52:17–32
Brugha R, Keersmaekers K, Renton A et al. (1997) Genital herpes infection: a review. Int J Epidemiol 26:698 – 709
Fricker J (1996) Herpes vaccines: spinning a new DISC. Lancet 348:1576
Goh CL, Khoo L (1998) A retrospective study on the clinical outcome of herpes zoster in patients treated with acyclovir or valaciclovir vs. patients not treated with antiviral. Int J Dermatol 37:544 – 546
Goodyear HM, McLeish P, Randall S et al. (1996) Immunological studies of herpes simplex virus infection in children with atopic eczema. Br J Dermatol 134:85 – 93
Pereira FA (1996) Herpes simplex: evolving concepts. J Am Acad Dermatol 35:503 – 520
Slomka MJ, Emery L, Munday PE et al. (1998) Comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 55:177–183
Tang WY, Lo JY, Yuen MK et al. (1997) Herpes simplex virus type 2 infection in a 5-year-old boy presenting with recurrent chest wall vesicles and a possible history of herpes encephalitis. Br J Dermatol 137:440–444
Wolf R, Wolf D, Ruocco V (1997) Antiviral therapy for recurrent herpes simplex reconsidered. Dermatology 194: 205–207
Varicella Zoster Virus
Arvin AM (1996) Varicella-zoster virus: overview and clinical manifestations. Semin Dermatol 15:4 – 7
Kakourou T, Theodoridou M, Mostrou G et al. (1998) Herpes zoster in children. J Am Acad Dermatol 39:207 – 210
Kost RG, Straus SE (1996) Postherpetic neuralgia — pathogenesis, treatment, and prevention. N Engl J Med 335: 32–42
Weller TH (1996) Varicella: historical perspective and clinical overview. J Infect Dis 174 [Suppl 3]: S306 – S309
White CJ (1997) Varicella-zoster virus vaccine. Clin Infect Dis 24:753–761
Epstein-Barr Virus
Cruchley AT, Williams DM, Niedobitek G et al. (1997) Epstein-Barr virus: biology and disease. Oral Dis 3:S156–S163
Itin PH, Lautenschlager S (1997) Viral lesions of the mouth in HIV-infected patients. Dermatology 194:1 – 7
Sangueza OP (1997) Epstein-Barr virus. A serial killer or an innocent bystander? Arch Dermatol 133:1156 – 1157
Voog E (1996) Genital viral infections. Studies on human papillomavirus and Epstein-Barr virus. Acta Derm Venereol (Stockh) [Suppl] 198:1–55
Cytomegalovirus
Grimes PE, Sevall JS, Vojdani A (1996) Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol 35:21 – 26
Human Herpes Virus-6 and Exanthema Subitum
Agut H (1993) Puzzles concerning the pathogenicity of human herpesvirus 6. N Engl J Med 329:203 – 204
Asano Y, Yoshikawa T, Suga S et al. (1994) Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 93: 104–108
Le Cleach L, Fillet AM, Agut H et al. (1998) Human herpesviruses 6 and 7. New roles yet to be discovered? Arch Dermatol 34:1155 – 1157
Linnavuori K, Peltola H, Hovi T (1992) Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum). Pediatrics 89:103 – 106
Zarhorsky J (1910) Roseola infantilis. Pediatrics 22:60–64
Human Herpes Virus-8
Kemeny L, Gyulai R, Kiss M et al. (1997) A Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology. J Am Acad Dermatol 37:107 – 113
Kowalzick L, Hoffmann I, Neipel F et al. (1998) Detection of HHV-8 DNA in a German patient. Eur J Dermatol 8:432–434
Porter SR, Di Alberti L, Kumar N (1998) Human herpes virus 8 (Kaposi’s sarcoma herpesvirus). Oral Oncol 34:5–14
Variola, Monkeypox, Cowpox
Baxby D, Bennett M, Getty B (1994) Human cowpox 1969 – 1993: a review based on 54 cases. Br J Dermatol 131:598 – 607
Duffill MB (1993) Milkers’ chilblains. N Z Med J 106:101 – 103
Stolz W, Gotz A, Thomas P, Ruzicka T, Suss R, Landthaler M, Mahnel H, Czerny CP (1996) Characteristic but unfamiliar — the cowpox infection, transmitted by a domestic cat. Dermatology 193:140 – 143
Milker’s Nodule
Groves RW, Wilson-Jones E, MacDonald DM (1991) Human orf and milker’s nodule: a clinicopathologic study. J Am Acad Dermatol 25:706 – 711
Hansen SK, Mertz H, Krogdahl A, Veien NK (1996) Milker’s nodule — a report of 15 cases in the county of North Jutland. Acta Derm Venereol (Stockh) 76:88
Ecthyma Contagiosum (Orf)
Macfarlane AW (1997) Human orf complicated by bullous pemphigoid. Br J Dermatol 137:656 – 657
Murphy JK, Ralfs IG (1996) Bullous pemphigoid complicating human orf. Br J Dermatol 134:929 – 930
Roingeard P, Machet L (1997) Images in clinical medicine. orf skin ulcer. N Engl J Med 337:1131
Yirrell DL, Vestey JP, Norval M (1994) Immune responses of patients to orf virus infection. Br J Dermatol 130:438 – 443
Molluscum Contagiosum
Bugert JJ, Darai G (1997) Recent advances in molluscum contagiosum virus research. Arch Virol [Suppl] 13:35 – 47
Gottlieb SL, Myskowski PL (1994) Molluscum contagiosum. Int J Dermatol 33:453 – 461
Janniger CK, Schwartz RA (1993) Molluscum contagiosum in children. Cutis 52:194 – 196
Lewis EJ, Lam M, Crutchfield CE III (1997) An update on molluscum contagiosum. Cutis 60:29 – 34
Myskowski PL (1997) Molluscum contagiosum. New insights, new directions. Arch Dermatol 133:1039 – 1041
Nehal KS, Sarnoff DS, Gotkin RH et al. (1998) Pulsed dye laser treatment of molluscum contagiosum in a patient with acquired immunodeficiency syndrome. Dermatol Surg 24:533–535
Ogg GS, Coleman R, Rosbotham JL et al. (1997) Atypical molluscum contagiosum — a diagnostic problem. Acta Derm Venereol (Stockh) 77:77–78
Coxsackie and Herpangina
Bauer K (1997) Foot- and mouth-disease as zoonosis. Arch Virol [Suppl] 13:95–97
Modlin JF, Rotbart HA (1997) Group B Coxsackie disease in children. Curr Top Microbiol Immunol 223:53 – 80
Resnick SD (1997) New aspects of exanthematous diseases of childhood. Dermatol Clin 15:257 – 266
Robinson CR, Doane FW, Rhodes AJ (1958) Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957 — isolation of group A Coxsackie virus. Can Med Assoc J 79:615 – 621
Shelley WB, Hashim M, Shelley ED (1996) Acyclovir in the treatment of hand-foot-and-mouth disease. Cutis 57:232–234
Smith PT, Landry ML, Carey H et al. (1998) Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review. Clin Infect Dis 27:164–168
Stolz W, Gotz A, Thomas P et al. (1996) Characteristic but unfamiliar — the cowpox infection, transmitted by a domestic cat. Dermatology 193:140–143
Zahorsky J (1924) Herpangina (a specific infectious disease). Arch Pediat 41:181–184
Measles
Atkinson WL (1995) Epidemiology and prevention of measles. Dermatol Clin 13:553 – 559
Bellini WJ, Rota JS, Rota PA (1994) Virology of measles virus. J Infect Dis 170: S15–S23
Dukes C (1881) The incubation period of scarlatina, varicella, parotis, and roetheln. Lancet 10:743 – 745
Garenne M, Glasser J, Levins R (1994) Disease, population and virulence. Thoughts about measles mortality. Ann N Y Acad Sci 740:297 – 302
Gellin BG (1994) Measles: state of the art and future directions. J Infect Dis 170 [Suppl 1]: S3 – S14
Griffin DE, Ward BJ, Esolen LM (1994) Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 170 [Suppl 1]:S24–S31
James JM, Burks AW, Roberson PK et al. (1995) Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med 332:1262 – 1266
Katz M (1995) Clinical spectrum of measles. In: ter Meulen V, Billeter MA (eds) Measles virus. Springer, Berlin, pp 1–12 (Current topics in microbiology and immunology, vol 191)
Liebert UG (1997) Measles virus infections of the central nervous system. Intervirology 40:176–184
Rubella
Arai M, Wada N, Maruyama K et al. (1995) Acute hepatitis in an adult with acquired rubella infection. J Gastroenterol 30:539–542
Cutts FT, Robertson SE, Diaz-Ortega JL et al. (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ 75:55 – 68
Frey TK(1997) Neurological aspects of rubella virus infection. Intervirolog 40:167–175
Murph JR (1994) Rubella and syphilis: continuing causes of congenital infection in the 1990s. Semin Pediatr Neurol 1:26–35
Robertson SE, Cutts FT, Samuel R et al. (1997) Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ 75:69 – 80
Skendzel LP (1996) Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 106:170 – 174
Erythema Infectiosum, Rubeola Scarlatinosa, Papular-Purpuric Gloves and Socks Syndrome, and Other Viral Infections
Bodemer C, de Prost Y (1992) Unilateral laterothoracic exanthem in children: a new disease? J Am Acad Dermatol 27:693–696
Brunner MJ, Rubin L, Dunlap F (1962) A new papular erythema of childhood. Arch Dermatol 85:539 – 540
Carrascosa JM, Just M, Ribera M et al. (1998) Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection. Cutis 61:265 – 267
Harms M, Feldmann R, Saurat JH (1990) Papular-purpuric “gloves and socks” syndrome. J Am Acad Dermatol 23:850–854
Manns A, Hisada M, La Grenade L (1999) Human T-lymphotropic virus type I infection. Lancet 353:1951 – 1958
McCuaig CC, Russo P, Powell J et al. (1996) Unilateral laterothoracic exanthem. J Am Acad Dermatol 34:979 – 984
Sticker G (1899) Die neue Kinderseuche in der Umgebung von Giessen (Erythema infectiosum). Zschr Prakt Ärzte 8:353–358
Sweet RD (1966) A pattern of eczema in Jamaica. Br J Dermatol 78:93–100
Vargas-Diez E, Buezo GF, Aragues M et al. (1996) Papularpurpuric gloves-and-socks syndrome. Int J Dermatol 35:626–632
Hepatitis
McElgunn PSJ (1983) Dermatologic manifestations of hepatitis B virus infection. J Am Acad Dermatol 8: 539–548
Ryder SD (1999) Viral hepatitis. In: Armstrong D, Cohen J (eds) Infectious diseases. Mosby, London, pp 1–12
AIDS
Allen JE (1993) Drug-induced photosensitivity. Clin Pharmacol 12:580–587
Balfour HH, Benson C, Braun J et al. (1994) Management of acyclovir-resistant herpes simplex and varicella zoster virus infections. J Acquir Immune Defic Syndr 7:254–260
Bailem PJ, Belzberg A, Devine PV et al. (1992) Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 327:1779–1784
Berger EA, Doms RW, Fenyö E-M et al. (1998) A new classification for HIV-1. Nature 391:240
Berger TG, Dhar A (1994) Lichenoid photoeruptions in human immunodeficiency virus infection. Arch Dermatol 140:609 – 613
Berry CD, Hooton TM, Collier AC (1987) Neurologie relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 316: 1387–1389
BHIVA Guidelines Co-ordinating Commitee (1997) British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Consensus statement. Lancet 349:1086 – 1092
Bogner JR, Kronawitter U, Rolinski B et al. (1994) Liposomal doxoribicin in the treatment of advanced AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr 7:453 – 569
Boisseau AM, Conzigou P, Forestier JF et al. (1991) Porphyria cutanea tarda associated with human immunodeficiency virus infection. Dermatologica 182:155–159
Bournèrias I, Biosnic S, Patey O et al. (1989) Unusual cutaneous cytomegalovirus involvment in patients with acquired immunodeficiency syndrome. Arch Dermatol 125:1243 – 1246
Bouscarat F, Bouchard C, Bouhour D (1998) Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. N Engl J Med 338:1776 – 1777
Brambilla L, Boneschi V, Beretta G et al. (1984) Intralesional chemotherapy for Kaposi’s sarcoma. Dermatologica 169: 150–155
Broder S, Merigan TC Jr, Bolognesi D (1994) Textbook of AIDS medicine. Williams and Wilkins, Baltimore
Buchness MR, Lim HW, Hatcher VA et al. (1988) Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. N Engl J Med 318:1183 – 1186
Carr A, Cooper DA (1995) Pathogenesis and management of HIV-associated drug hypersensitivity. AIDS Clin Rev 96:65–97
Carr A, Samaras K, Thorisdottir A et al. (1999) Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353:2093 – 2099
Casanova JM, Puig T, Rubio M (1987) Hypertrichosis of the eyelashes in acquired immuno-deficiency syndrome. Arch Dermatol 123:1599 – 1601
Caumes E, Guermonprez G, Lecomte C et al. (1997) Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Arch Dermatol 133:465 – 469
Cavert W, Notermans DW, Staskus K et al. (1997) Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-i infection. Science 276:960 – 964
Center for Disease Control and Prevention MMWR (1993) Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Arch Dermatol 129:287–290
Chun TW, Carruth L, Finzl D et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183 – 187
Cohen PR, Grossman ME, Silvers DN et al. (1990) Generalized granuloma anulare located in sunexposed areas in a human immunodeficiency virus-seropositive man with ultraviolet B photosensitivity. Arch Dermatol 126: 830–831
Conant MA (1987) Hairy leukoplakia. A new disease of the oral mucosa. Arch Dermatol 123:585 – 587
Coodley GO, Loveless MO, Merrill TM (1994) The HIV wasting syndrome: a review. J Acquir Immune Defic Syndr 7:681–694
Coopman SA, Johnson RA, Platt R et al. (1993) Cutaneous disease and drug reactions in HIV infection. N Engl J Med 328:1670 – 1674
Corbett EL, Crossley I, Holton J et al. (1996) Crusted (“Norwegian”) scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med 72:115–117
Coulman CU, Greene I, Archibald RWR (1987) Cutaneous pneumocystosis. Ann Intern Med 106:396–398
Deutsche AIDS-Gesellschaft (DAIG), Österreichische AIDS-Gesellschaft (ÖAG), Robert-Koch-Institut (RKI) et al. (1997) German-Austrian guidelines for antiretroviral therapy of HIV infection. Eur J Med Res 2:535–542
DeVita VT Jr, Hellmann S, Rosenberg SA et al. (1997) AIDS. Etiology, diagnosis, treatment and prevention, 4th edn. Lippincott-Raven, Philadelphia
Duvic M, Johnson TM, Rapini RP et al. (1987) Acquired immunodeficiency syndrome — associated psoriasis and Reiter’s syndrome. Arch Dermatol 123:1622–1632
Fahey JL, Tailor JMG, Detels R et al. (1987/1990) The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type I. N Engl J Med 322:166–172
Frentz G, Niordson AM, Thomsen K (1989) Eosinophilic pustular dermatosis: an early skin marker of infection with human immunodeficiency virus? Br J Dermatol 121:271–274
Friedman-Kien AE, Saltzman BR (1990) Cilinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi’s sarcoma. J Am Acad Dermatol 22: 1237–1250
Friedman-Kien AE, Laubsenstein L, Marmor M et al. (1981) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men — New York and California MMWR 30:250–252
Gallant JE, Moore RD, Chaisson RE (1994) Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 120:932 – 944
Gallo RC, Salahuddin SZ, Popovic M et al. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500 – 503
Gaudreau A, Hill E, Balfour HH Jr et al. (1998) Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 178:297–303
Gazzard B, Moyle G (1997) Anti-infectives — to sequence or not to sequence? Exp Opin Invest Drugs 6:99 – 102
Glover R, Young L, Goltz RW (1987) Norwegian scabies in acquired immunodeficiency syndrome: report of a case resulting in death from associated sepsis. J Am Acad Dermatol 16:396–399
Goldstein B, Berman B, Sukenik E et al. (1997) Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS. J Am Acad Dermatol 36: 262–264
Greenberg RG, Berger TG (1990) Nail and mucocutaneous hyperpigmentation with azidothyidine therapy. J Am Acad Dermatol 22:327–330
Greenspan D, Greenspan JS, Hearst NG et al. (1987) Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 155:475 – 481
Gregory N, Sanchez M, Buchness MR (1990) The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol 22:1061 – 1067
Gürtler LG, Hauser PH, Eberle J et al. (1994) A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 68:1581 – 1585
Gürtler LG, Hauser PH, Eberle J et al. (1994) Guidelines for the management of health care worker exposures to HIV and recommendation for postexposure prophylaxis. MMWR (1998) 134:1317–1318;
Gürtler LG, Hauser PH, Eberle J et al. (1994) Guidelines for the management of health care worker exposures to HIV and recommendation for postexposure prophylaxis Arch Dermatol 134:1317–1318
Heng MCY, Heng SY, Allen SG (1994) Co-infection and synergy of human immunodeficiency virus-1. Lancet 343: 255–258
Hengel RL, Watts NB, Lennox JL (1997) Benign symmetric lipomatosis associated with protease inhibitors. Lancet 350:1596
Hevia O, Jiminez-Acosta F, Ceballos PI et al. (1991) Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J Am Acad Dermatol 24:231 – 235
Hirsch MS, D’Aquila RT (1993) Therapy for human immunodeficiency virus infection. N Engl J Med 328:1686 – 1695
Hoegl L, Thoma-Greber E, Röcken M et al. (1998) HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year-study. Mycoses 41:321 – 325
Inwald D, Nelson M, Cramp M et al. (1994) Cutaneous manifestations of mycobacterial infection in patients with AIDS. Br J Dermatol 130:111 – 114
Jaffe D, May LP, Sanchez M et al. (1991) Staphylococcal sepsis in HIV antibody seropositive psoriasis patients. J Am Acad Dermatol 24:970 – 972
Jasny B, Cohen G, Merson H et al. (1993) AIDS. The unanswered questions. Science 260:1253 – 1292
Kaposi M (1872) Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph 4:265 – 272
Katz DH (1993) AIDS: primarily a viral or an autoimmune disease? AIDS Res Hum Retroviruses 9:489 – 493
Kopelman RG, Zolla-Pazner S (1988) Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 84:83 – 89
Krown SE, Gold JWM, Niedzwiecki D et al. (1994) Interferon-α with zidovudine: safety, tolerance and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812–821
Lane HC, Laughton BE, Falloon J et al. (1994) Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med 120:945 – 955
Lo J, Mulligan K, Tai VW et al. (1998) “Buffalo hump” in men with HIV-1 infection. Lancet 351:867–870
Magro CMJ, Crowson AN (1994) Eosinophilic pustular folliculitis reaction: a paradigm of immune dysregulation. Int J Dermatol 33:172 – 178
Malone JL, Wallace MR, Hendrick BB et al. (1995) Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1:55 – 63
McNeely MC, Yarchoan R, Broder S et al. (1989) Dermatologic complications associated with administration of 2′,3′-dideoxycytidine in patients with human immunodeficiency virus infection. J Am Acad Dermatol 21:213 – 217
Meola T, Soter NA, Ostreicher R et al. (1993) The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 29:216 – 220
Mirowski GW, Hilton JF, Greenspan D et al. (1998) Association of cutaneous and oral diseases in HIV-infected men. Oral Dis 4:16–21
Mitsuyasu RT, Taylor JM, Glaspy J et al. (1986) Heterogeneity of epidemic Kaposi’s sarcoma. Implications for therapy. Cancer 57 (8 Suppl): 1657–1661
Mole L, Ripich S, Margolis D et al. (1997) The impact of active herpes simplex infection on human immunodeficiency virus load. J Infect Dis 176:766 – 770
Palefsky JM, Holly EA, Ralston ML et al. (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177:361–367
Pantaleo G, Graziosi C, Fauci AS (1993) The immunopatho-genesis of human immunodeficiency virus infection. N Engl J Med 328:327 – 332
Pechere M, Wunderli W, Trellu-Toutous L et al. (1998) Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis. Dermatology 197:278 – 280
Perelson AS, Essunger P, Cao Y et al. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188 – 191
Perrin L, Schockmel GA (1997) Should clinicians watch for and treat primary HIV infection? HIV 7:17 – 23
Portu JJ, Santamaria JM, Zubero Z et al. (1996) Atypical scabies in HIV-positive patients. J Am Acad Dermatol 34:915–917
Presant CA, Scoriaro M, Kennedy P et al. (1993) Liposomal daunorubicin treatment of HIV-associated Kaposi’s sarcoma. Lancet 341:1242 – 1243
Ranki A, Puska P, Mattinen S et al. (1991) Effect of PUVA on immunologic and virologie findings in HIV-infected patients. J Am Acad Dermatol 24:404 – 410
Rizzuto CD, Wyatt R, Hernández-Ramos N et al. (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949 – 1953
Rosenthal D, LeBoit PE, Klumpp L et al. (1991) Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatotis associated with advanced human immunodeficiency virus infection. Arch Dermatol 127:206–209
Royce RA, Sena A, Cates W Jr et al. (1997) Sexual transmission of HIV. N Engl J Med 336:1072 – 1078
Ruzicka T, Fröschl M, Hohenleutner U et al. (1987) Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine. Lancet 2:1469 – 1470
Samaranayake LP (1992) Oral mycoses in HIV infection. Oral Surg Med Oral Pathol 73:171 – 180
Schacker T, Zehl J, Hu HL et al. (1998) Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 178:1616 – 1622
Schaller M, Hube B, Ollert MW et al. (1999) In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol 112:383–386
Schlüpen EM, Schirren CG, Hoegl L et al. (1997) Molecular diagnosis of deep nodular bacillary angiomatosis and monitoring of therapeutic success. Br J Dermatol 136: 747–751
Schöfer H, Ochsendorf FR, Helm EB et al. (1987) Treatment of oral “hairy” leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically). Dermatologica 174:150–153
Schöpfer H, Imhof M, Thoma-Greber E et al. (1996) Active Syphilis in HIV infection: a multicentre retrospective survey. Genitourin Med 72:176 – 181
Segal BH, Engler HD, Little R et al. (1997) Early foscarnet failure in herpes simplex virus infection in a patients with AIDS. AIDS 11:552 – 553
Tappero JW, Conant MA, Wolfe SF et al. (1993) Kaposi’s sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 28:371–395
Taylor JF, Templeton AC, Vogel CL et al. (1971) Kaposi’s sarcoma in Uganda: a clinicopathological study. Int J Cancer 8(1): 122–135
Templeton AC (1981) Kaposi’s sarcoma. Pathol Annu 16 (Pt 2):315–336
Toome BK, Bowers KE, Scott GA (1991) Diagnosis of cutaneous cytomegalovirus infection: a review of cutaneous cytomegalovirus infection: a review and report of a case. J Am Acad Dermatol 24:857 – 863
Williams CA, Winkler JR, Grassi M et al. (1990) HIV-associated periodontitis complicated by necrotizing stomatitis. Oral Surg Oral Med Oral Pathol 69:351–355
Wright S, Johnson RA (1997) Human immunodeficiency virus in women: mucocutaneous manifestations. Clin Dermatol 15:93 – 111
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C. (2000). Viral Diseases. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97931-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-97931-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97933-0
Online ISBN: 978-3-642-97931-6
eBook Packages: Springer Book Archive